CN102731521A - Chromone compound in aromatic tobaccos, preparation method and application thereof - Google Patents

Chromone compound in aromatic tobaccos, preparation method and application thereof Download PDF

Info

Publication number
CN102731521A
CN102731521A CN2012102333170A CN201210233317A CN102731521A CN 102731521 A CN102731521 A CN 102731521A CN 2012102333170 A CN2012102333170 A CN 2012102333170A CN 201210233317 A CN201210233317 A CN 201210233317A CN 102731521 A CN102731521 A CN 102731521A
Authority
CN
China
Prior art keywords
compound
chromone
preparation
tobacco
silica gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012102333170A
Other languages
Chinese (zh)
Inventor
杨光宇
段沅杏
赵伟
王岚
陈永宽
缪明明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Academy of Tobacco Science
Original Assignee
Yunnan Academy of Tobacco Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Academy of Tobacco Science filed Critical Yunnan Academy of Tobacco Science
Priority to CN2012102333170A priority Critical patent/CN102731521A/en
Publication of CN102731521A publication Critical patent/CN102731521A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a chromone compound in aromatic tobaccos, a preparation method of the chromone compound and application of the chromone compound, which belong to the field of tobacco chemistry, in particular to a novel chromone compound contained in the aromatic tobaccos, a preparation method of the novel chromone compound and an antibacterial activity of the novel chromone compound. The preparation method comprises the following steps of: pulverizing an aromatic tobacco sample, and then carrying out ultrasonic extraction by using 95% alcohol for three times; merging the extraction solutions, decompressing and concentrating the obtained merged extraction solution into an extract; carrying out primary chromatography and fractionation on the extract by using a silicagel column; and then carrying out further separation by adopting a high-pressure liquid chromatogram method to obtain the required compound, namely tobchromone A. The compound has a simple structure, can be artificially synthesized easily, has good antibacterial activity and exerts antibacterial effects on ordinary proteus, escherichia coli, staphylococcus, bacillus subtilis, and the like.

Description

Chromone compounds in a kind of Turkish tobaccos
Technical field
The invention belongs to the tobacco chemistry field, more particularly, the present invention relates to contained chromone compounds and preparation method thereof in a kind of new Turkish tobaccos; Simultaneously, the anti-microbial activity that also relates to this compound.
Background technology
Tobacco is to contain maximum a kind of of chemical substance in human each kind of plant of being familiar with, and through the research of decades, people identify from tobacco that at present the monomer chemical substance of coming out just surpasses kind more than 3000, and also have many compositions to identify as yet.Tobacco also can therefrom be extracted the multiple chemical ingredients that the value utilized is arranged except that being mainly used in the cigarette smoking purposes, therefrom find to have the guiding compound of value of exploiting and utilizing.Therefore, except that consuming as cigarette, the research of strengthening other purposes of tobacco is also significant.
Turkish tobaccos are claimed Turkey's cigarette, east type cigarette again, originate in Mediterranean Sea coastwise contries, are a kind of special tobacco types of safflower tobacco (Nicotiana tobacum).Because Turkish tobaccos have strong fragrance and pure jealous quality characteristic, are one of important source material of production mixed type, outer odor type and oriental type cigarette and pipe tobacco.In China, Turkish tobaccos have establishing in large scale in the Baoshan, Yunnan at present.
Chromone (chromone) is the biologically active substance that one type of occurring in nature extensively exists, because of the most coloured chromone of gaining the name of this compounds.Because plant chromone constituent structure type is many, stereochemistry is complicated, has multiple biological activity, and is very active to the research in this field both at home and abroad; No matter be naturally occurring, or the chromone compounds that obtains of synthetic, chemist's extensive concern all caused.But through the present report that does not also have chromone compounds in the Turkish tobaccos of document retrieval.
Summary of the invention
The object of the present invention is to provide the chromone compounds that separation obtains in the Turkish tobaccos of the Baoshan, a kind of Yunnan.
Another object of the present invention provides a kind of preparation method of said compound.
Further purpose of the present invention provides the anti-microbial activity of said compound.
The object of the invention is achieved through following technical proposals.
A. the present invention separates from the Turkish tobaccos of the Baoshan, Yunnan and obtains chromone compounds, and this compound has following structural formula:
Figure BDA0000185741701
The called after of this compound: tobacco chromone A (Tobchromone A).
B. the invention provides the preparation method of described chromonic compound, this method adopts following step to accomplish:
(1) the Turkish tobaccos sample is pulverized the back and is divided with the ethanol of 95 % V/V and use supersound extraction 3~5 times, united extraction liquid, and concentrating under reduced pressure becomes medicinal extract;
(2) medicinal extract just divides with silica gel column chromatography, adopts HPLC further to separate then, promptly obtains required compound.
The concrete steps of the inventive method are:
(1) is crushed to 20~40 orders with Turkish tobaccos;
(2) be solvent with 95%V/V ethanol, with supersound extraction 3~5, each 30~60 minutes;
(3) medicinal extract is with 80~100 purpose silica gel mixed samples; Carry out the silica gel column chromatography rough segmentation with 80~200 purpose silica gel dry column-packings; With the quality proportioning that chloroform-acetone is pressed 20:1,9:1,8:2,7:3,5:5 respectively, carry out gradient elution, collect various piece elutriant and concentrated; The 8:2 part of elutriant is further used HPLC (special-purpose in the industry) separation and purification, adopts the C of 20 mm * 250 mm 18Chromatographic column, flow velocity is 15 mL/min, is moving phase with the methanol, progressively adjusts the two ratio and segments step by step, promptly obtains required chromone compounds.
C. this compound has been carried out the anti-microbial activity screening, it has significant activity to proteus vulgaris, intestinal bacteria, staphylococcus, subtilis, sarcina, penicillium spp, Aspergillus flavus and black-koji mould etc.; Wherein the bacteriostasis rate to proteus vulgaris, intestinal bacteria, staphylococcus and subtilis reaches more than 85%.
The invention has the beneficial effects as follows: The compounds of this invention is simple in structure, and synthetic realizes that easily the compound anti-microbial activity is good, and the bacteriostasis rates of proteus vulgaris, intestinal bacteria, staphylococcus, subtilis etc. is reached more than 85%; Can be used as the guiding compound of anti-microbial type drug development.
Description of drawings
Fig. 1 be The compounds of this invention proton nmr spectra ( 1H NMR) figure.
Fig. 2 be The compounds of this invention carbon-13 nmr spectra ( 13C NMR) figure.
Fig. 3 is the main HMBC correlogram of The compounds of this invention.
Embodiment
In order to make the object of the invention, technical scheme and advantage clearer,, the present invention is further elaborated below in conjunction with accompanying drawing and embodiment.Should be appreciated that specific embodiment described herein only in order to explanation the present invention, and be not used in qualification the present invention.
Embodiment 1---and compound extracts and separates
The Turkish tobaccos sample is adopted in the Baoshan, Yunnan, and kind is the Bath horse.Turkish tobaccos complete stool sampling 1.5~2.5 kg are crushed to 20~40 orders, and with supersound extraction 3 times, each 30~60 minutes, extracting solution merged, filtration with the ethanol of 95%V/V, and concentrating under reduced pressure becomes medicinal extract.Medicinal extract is mixed appearance with an amount of methyl alcohol (medicinal extract weight 1.5 times) dissolving back with the thick silica gel of 80~120 g (80~100 order), and 1.5~2.0 kg silica gel (80~200 order) are adorned post and carried out silica gel column chromatography.Chloroform-acetone (gradient elution of 20:1 → 1:1), the TLC monitoring merges identical part, obtains 5 parts; Wherein chloroform-acetone (8:2) wash-out partly separates with the prompt logical sequence 1,100 half preparation HPLies of peace; Methyl alcohol with 46% is moving phase, the C of (20 mm * 250 mm, 5 μ m) 18Preparative column is a stationary phase, and flow velocity is 15 mL/min, and it is 254 nm that UV-detector detects wavelength, and each sample introduction 200 μ L collect the chromatographic peak of 22.8 min, and the back evaporate to dryness repeatedly adds up; The gained material is used pure dissolve with methanol once more, is moving phase with pure methyl alcohol again, separates with Sephadex LH-20 gel filtration chromatography, get final product this new compound.
Embodiment 2---the evaluation of compound:
Table-1 compound 1H with 13C NMR data
position C?(mult.)? H?(mult, J,?Hz)
2 167.2?s
3 108.0?d 6.34,?s
4 180.9?s
5 161.3?s
6 100.5?d 6.21,?s
7 159.2?s
8 101.8?s
9 158.4?s
10 107.4?s
11 36.2?t 2.57,?d,?J?=?8.1
12 32.0?t 1.89,?m
13 62.7?t 3.58,?d,?J?=?6.3
14 115.1?d 6.63,?d,?J?=?10.0
15 127.8?d 5.64,?d,?J?=?10.0
16 77.8?s
17,?18 27.7?q 1.50,?s
Ar-OH 10.73?brs
This patent compound is orange-yellow jelly; UV spectrum (solvent is a methyl alcohol), λ Max(log ε) 222 (4.51), 245 (3.97), 268 (4.22), 358 (4.02) nm; Ir spectra (pressing potassium bromide troche) v Max3392,2962,2881,1726,1662,1623,1584,1426,1375,1329,1284,1172,1128,853 cm -1High resolution mass spectrum (HRESIMS) provides quasi-molecular ion peak m/z 301.1067 [M-H] -(calculated value 301.1076).In conjunction with 1H with 13C NMR spectrum provides a molecular formula C 17H 18O 5, degree of unsaturation is 9.From 1H with 13CNMR spectrum (figure-1 and figure-2, attribution data is seen table-1) signal can find out in the compound except that the chromone parent, 1 phenolic hydroxyl group signal in addition, 1 group of 3-hydroxypropyl signal, 1 group of gem-dimethyl chromene ring signal.Can infer that from HMBC is relevant phenolic hydroxyl group is substituted in the C-5 position of chromone ring, the 3-hydroxypropyl is substituted in the C-2 position of chromone ring, and gem-dimethyl chromene ring is substituted in the C-7 and the C-8 position of chromone ring, and the structure of compound obtains confirming since then.This compound is named as tobacco chromone A.
Embodiment 3---and anti-microbial activity detects and uses:
The in-vitro antibacterial experiment is carried out with agar diffusion method, and test strain is proteus vulgaris, intestinal bacteria, staphylococcus, subtilis, sarcina, penicillium spp, Aspergillus flavus, black-koji mould.At first will be tried on the flat board that bacterium is coated in plain agar substratum (Carnis Bovis seu Bubali cream, peptone, sodium-chlor, serum, agar) equably; (The compounds of this invention dissolves with 10 mL DMSO with testing compound again; Thin up becomes the solution of 50 g/mL) soaked tablet (diameter 5 mm) is placed on the germ-carrying substratum; Put into thermostat container, observe the inhibition zone size after hatching 24-72 h in 25 ℃.The result shows: The compounds of this invention has very strong activity to proteus vulgaris, intestinal bacteria, staphylococcus and subtilis, and inhibiting rate surpasses 85%, and other experimental strain is also had tangible resistance.
The compounds of this invention has been carried out safety evaluation,, proved that The compounds of this invention is nontoxic to animal through mouse bone marrow cells micronucleus test, Ames experiment and TK transgenation experiment, safe in utilization.
This compound is added on the cigarette tipping paper with the concentration of 50 g/mL; By the detection method of the GB15979-2002 of the People's Republic of China's " disposable use sanitary product hygienic standard ", get the cigarette that added The compounds of this invention and use tipping paper, 2.0 * 3.0 mm size, bacterial detection sum, total number of fungi.The result shows that the tipping paper total number of bacterial colony of adding The compounds of this invention obviously reduces, and the bacteriums of several kinds of tests are all had obvious restraining effect, and the bacteriostasis rate of proteus vulgaris, intestinal bacteria, staphylococcus and subtilis is all reached more than 72%.

Claims (4)

1. the middle chromone compounds that grows tobacco is characterized in that: this compound separates from the Turkish tobaccos of the Baoshan, Yunnan and obtains, and structural formula is:
Figure FDA0000185741691
?,
The called after of this compound, tobacco chromone A (Tobchromone A).
2. the preparation method of chromone compounds in the said tobacco of claim 1 is characterized in that, this method adopts following steps preparation:
(1) the Turkish tobaccos sample is pulverized the back and is divided with the ethanol of 95 % V/V and use supersound extraction 3~5 times, united extraction liquid, and concentrating under reduced pressure becomes medicinal extract;
(2) medicinal extract just divides with silica gel column chromatography, adopts HPLC further to separate then, promptly obtains required compound.
3. by the preparation method of chromone compounds in the said tobacco of claim 2, it is characterized in that concrete steps are:
(1) is crushed to 20~40 orders with Turkish tobaccos;
(2) be solvent with 95%V/V ethanol, with supersound extraction 3~5, each 30~60 minutes;
(3) medicinal extract is with 80~100 purpose silica gel mixed samples; Carry out the silica gel column chromatography rough segmentation with 80~200 purpose silica gel dry column-packings; With the quality proportioning that chloroform-acetone is pressed 20:1,9:1,8:2,7:3,5:5 respectively, carry out gradient elution, collect various piece elutriant and concentrated; The 8:2 part of elutriant is further used the HPLC separation and purification, adopts the C of 20 mm * 250 mm 18Chromatographic column, flow velocity is 15 mL/min, is moving phase with the methanol, progressively adjusts the two ratio and segments step by step, promptly obtains required chromone compounds.
In the described tobacco of claim 1 chromone compounds to the application in proteus vulgaris, intestinal bacteria, staphylococcus, subtilis, sarcina, penicillium spp, Aspergillus flavus and black-koji mould antibiotic.
CN2012102333170A 2012-07-06 2012-07-06 Chromone compound in aromatic tobaccos, preparation method and application thereof Pending CN102731521A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012102333170A CN102731521A (en) 2012-07-06 2012-07-06 Chromone compound in aromatic tobaccos, preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012102333170A CN102731521A (en) 2012-07-06 2012-07-06 Chromone compound in aromatic tobaccos, preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN102731521A true CN102731521A (en) 2012-10-17

Family

ID=46987897

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012102333170A Pending CN102731521A (en) 2012-07-06 2012-07-06 Chromone compound in aromatic tobaccos, preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN102731521A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103756945A (en) * 2014-02-11 2014-04-30 河南中烟工业有限责任公司 Bacillus subtilis strain xp, bacterium-enzyme combined preparation and application of bacterium-enzyme combined preparation to degradation of starch compound in tobacco product

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006069906A (en) * 2004-08-31 2006-03-16 Sumitomo Chemical Co Ltd Chromone compound and its use
CN1935803A (en) * 2006-10-18 2007-03-28 浙江工业大学 Method for preparing 3-formacyl chromone derivative

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006069906A (en) * 2004-08-31 2006-03-16 Sumitomo Chemical Co Ltd Chromone compound and its use
CN1935803A (en) * 2006-10-18 2007-03-28 浙江工业大学 Method for preparing 3-formacyl chromone derivative

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
A. G. GONZALEZ,等: "Chemotherapeutic study of chromones from Spanish Cneoraceae", 《PLANTA MEDICA》 *
DULCIE A. MULHOLLAND,等: "Cedkathryns A and B, pentanortriterpenoids from Cedrelopsis gracilis (Ptaeroxylaceae)", 《PHYTOCHEMISTRY》 *
R.D.H.MURRAY,等: "Infrared studies of chromones. I. Carbonyl and hydroxyl regions", 《TETRAHEDRON》 *
TUNTIWACHWUTTIKUL PITTAYA,等: "Chromones from the Branches of Harrisonia perforata", 《CHEMICAL & PHARMACEUTICAL BULLETIN》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103756945A (en) * 2014-02-11 2014-04-30 河南中烟工业有限责任公司 Bacillus subtilis strain xp, bacterium-enzyme combined preparation and application of bacterium-enzyme combined preparation to degradation of starch compound in tobacco product
CN103756945B (en) * 2014-02-11 2015-12-02 河南中烟工业有限责任公司 Bacillus subtilis strain xp, bacterium enzyme combined preparation and the application in degrading tobacco goods in starchy compounds thereof

Similar Documents

Publication Publication Date Title
CN102351827A (en) Isoflavone compound in tobacco rhizome and preparation method and application thereof
Kosalec et al. Flavonoid analysis and antimicrobial activity of commercially available propolis products
Das et al. Phytochemical extraction and characterization of the leaves of Aloe vera barbadensis for its anti-bacterial and anti-oxidant activity
CN106117138A (en) A kind of isoquinoline alkaloids alkaloid compound, its preparation method and application with antibacterial activity
CN103554077B (en) Chromone compound as well as preparation method and application thereof
CN105924356B (en) A kind of sesquiterpenoids and its preparation method and application
CN107162891B (en) Naphthalene compound extracted from lavender and preparation method and application thereof
CN102977065B (en) Flavonoid compound and preparation method and application thereof
CN106565654B (en) A kind of novel flavone compound, Its Preparation Method And Use extracted from Bai Yun Shen
CN102977059B (en) Phenylpropanoid compound, and preparation method and application thereof
CN102731521A (en) Chromone compound in aromatic tobaccos, preparation method and application thereof
CN105175233B (en) A kind of sesquiterpenoids and preparation method and application
CN107324983B (en) Polysubstituent naphthalene compound and preparation method and application thereof
Simões et al. Ipomopsin and hymenain, two biscoumarins from seeds of Hymenaea courbaril
CN107540532B (en) Diphenyl ether compound with antibacterial activity in honeysuckle and preparation method and application thereof
CN102649712B (en) Lignan compound in magnolia as well as preparation method and application thereof
CN111018822B (en) Compound with bacteriostatic action, preparation method thereof and application thereof in cigarettes
CN101084985B (en) separation and identification of highly effective antibiotic anti-oxidant active part of glycyrrhiza
CN105906566B (en) A kind of alkaloid compound, preparation method and use with antibacterial activity in tobacco
CN102653532B (en) Lignans compound in aromatic tobacco and preparation method and application of lignans compound
CN115745759B (en) A sesquiterpene compound extracted from sun-cured tobacco stem bark, and its preparation method and application
CN108911958B (en) Naphthalene formaldehyde compound with antibacterial activity, preparation method thereof and application of compound in cigarette paper
CN116063161B (en) Sesquiterpene compound with cedarwood fragrance and preparation method and application thereof
CN111423406B (en) Pyranolactone compound and preparation method and application thereof
CN105646411B (en) A kind of application of 2- carboxyls furfuran compound, preparation method and its antibacterial activity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121017